Frontlight ResearchEarly access
Trial site
Nagano
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Polymyalgia rheumatica2 trials
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Giant cell arteritis1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 32 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals5 trials
Running trials
Active, not recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Closed trials
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Site data: ClinicalTrials.govUpdated 15 Nov 2026